Seroreversion in children born to HIV-positive and AIDS mothers from Central West Brazil

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 103, Issue 6, 2009, Pages 620-626

  Alcântara, Keila C ^a   Pereira, Gisner A S ^a   Albuquerque, Maly ^a   Stefani, Mariane M A ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

AIDS; Brazil; Breastfeeding; HIV; Seroreversion; Vertical transmission

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; GAG PROTEIN; NEVIRAPINE; VIRUS ENVELOPE PROTEIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BIRTH WEIGHT; BRAZIL; BREAST FEEDING; CD4+ T LYMPHOCYTE; CHILD; DELIVERY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; INFECTION PREVENTION; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOTHER; NEWBORN; NEWBORN DEATH; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; VERTICAL TRANSMISSION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; BRAZIL; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK ASSESSMENT; VIRAL LOAD; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 67349087991     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2009.03.016     Document Type: Article

References (31)

1. UNAIDS/WHO. AIDS Epidemic Update December 2004 (2004), World Health Organization, Geneva
2. Ministério da Saúde, Brazil, 2006. Boletim Epidemiologico AIDS/DST - Janeiro a Junho de 2006. Brasília - DF: Ministério da Saúde, Secretaria de Vigilância em Saúde, Programa Nacional de DST e Aids.
3. Bongertz V., Bou-Habib D.C., Brigido L.F., Caseiro M., Chequer P.J., Couto-Fernandez J.C., et al. HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization. J. Acquir. Immune Defic. Syndr. 23 (2000) 184-193
4. Brindeiro R.M., Diaz R.S., Sabino E.C., Morgado M.G., Pires I.L., Brigido L., et al., the Brazilian Network for Drug Resistance Surveillance. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals. AIDS 17 (2003) 1063-1069
5. De Sa Filho D.J., Sucupira M.C., Casiero M.M., Sabino E.C., Diaz R.S., and Janini L.M. Identification of two HIV type 1 circulating recombinant forms in Brazil. AIDS Res. Hum. Retroviruses 22 (2006) 1-13
6. Stefani M.M., Pereira G.A., Martelli C.M., Shindo N., and Galvao-Castro B. Evidence of HIV-1 genetic diversity among pregnant women with AIDS or infected with HIV-1 in Central Brazil. J. Acquir. Immune Defic. Syndr. 23 (2000) 205-207
7. Stefani M.M., Pereira G.A., Lins J.A.B., Alcântara K.C., Silveira A.A., Viegas A.A., et al. Molecular screening shows extensive HIV-1 genetic diversity in Central West Brazil. J. Clin. Virol. 39 (2007) 205-209
8. Connor E.M., Sperling R.S., Gelber R., Kiselev P., Scott G., O'Sullivan M.J., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331 (1994) 1173-1180
9. Suksomboon N., Poolsup N., and Ket-Aim S. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection. J. Clin. Pharm. Ther. 32 (2007) 293-311
10. Young N.L., Shaffer N., Chaowanachan T., Chotpitayasunondh T., Vonparapar N., Mock P.A., et al. Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non B subtypes. J. Acquir. Immune Defic. Syndr. 24 (2000) 401-407
11. Coovadia H.M., Rollins N.C., Bland R.M., Little K., Coutsoudis A., Bennish M.L., et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 369 (2007) 1107-1116
12. Schulte J., Dominguez K., Sukalac T., Bohannon B., Fowler M.G., and Pediatric Spectrum of HIV Disease Consortium. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004. Pediatrics 119 (2007) 900-906
13. Delwart E.L., Shpaer E.G., Louwagie J., McCutchan F.E., Grez M., Rubsamen-Waigmann H., et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262 (1993) 1257-1261
14. Heyndrickx L., Janssens W., Zekeng L., Musonda R., Anagonou S., Van der Auwera G., et al. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities. J. Virol. 74 (2000) 363-370
15. Blackard J.T., Renjifo B., Fawzi W., Hertzmark E., Msamanga G., Mwakagile D., et al. HIV-1 LTR subtype and perinatal transmission. Virology 287 (2001) 261-265
16. Kamara P., Melendez-Guerrero L., Arroyo M., Weiss H., and Jolly P. Maternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective study. Virol. J. 24 (2005) 2-15
17. Fawzi W., Msamanga G., Renjifo B., Spiegelman D., Urassa E., Hashemi L., et al. Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian Women. AIDS 15 (2001) 1157-1165
18. Newell M.L. Current issues in the prevention of mother to child transmission of HIV-1 infection. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 1-5
19. Goldstein P.J., Smit R., Stevens M., and Sever J.L. Association between HIV in pregnancy and antiretroviral therapy, including protease inhibitors and low birth weight infants. Infect. Dis. Obstet. Gynecol. 8 (2000) 94-98
20. Thorne C., Patel D., and Newell M.L. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 18 (2004) 2337-2339
21. Szyld E.G., Warley E.M., Freimanis L., Gonin R., Cahn P.E., Calvet G.A., et al., NISDI Perinatal Study Group. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth. AIDS 20 (2006) 2345-2353
22. Lagro M., Liche A., Mumba T., Ntebeka R., and van Roosmalen J. Postpartum care attendance at a rural district hospital in Zambia. Trop. Doct. 36 (2006) 205-208
23. Nabukera S.K., Witte K., Muchunguzi C., Bajunirwe F., Batwala V.K., Mulogo E.M., et al. Use of postpartum health services in rural Uganda: knowledge, attitudes, and barriers. J. Community Health 31 (2006) 84-93
24. Pereira G.A., Stefani M.M.A., Araujo Filho J.A., Souza L.C., Stefani G.P., and Martelli C.M. Human immunodeficiency virus type 1 (HIV-1) and Mycobacterium leprae co-infection: HIV-1 subtypes and clinical, immunologic, and histopathologic profiles in a Brazilian cohort. Am. J. Trop. Med. Hyg. 71 (2004) 679-684
25. Pereira G.A., Stefani M.M.A., Martelli C.M., Turchi M.D., Siqueira E.M., Carneiro M.A., et al. Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil. J. Med. Virol. 78 (2006) 719-723
26. Murray M.C., Embree J.E., Ramdahin S.G., Anzala A.O., Njenga S., and Plummer F.A. Effect of human immunodeficiency virus (HIV) type 1 viral genotype on mother-to-child transmission of HIV-1. J. Infect. Dis. 181 (2000) 746-749
27. Long E.M., Martin H.L., Kreiss J.K., Rainwater S.M., Lavreys L., Jackson D.J., et al. Gender differences in HIV-1 diversity at time of infection. Nat. Med. 6 (2000) 23-25
28. Bakshi S.S., Tetali S., Abrams E.J., Paul M.O., and Pahwa S.G. Repeatedly positive human immunodeficiency virus type 1 DNA polymerase chain reaction in human immunodeficiency virus-exposed seroreverting infants. Pediatr Infect Dis J 14 (1995) 658-662
29. Lepage P., Van de Perre P., Simonon A., Msellati P., Hitimana D.G., and Dabis F. Transient seroreversion in children born to human immunodeficiency virus 1-infected mothers. Pediatr. Infect. Dis. J. 11 (1992) 892-894
30. Gutierrez M., Soriano V., Bravo R., Vallejo A., and Gonzalez-Lahoz J. Seroreversion in patients with end-stage HIV infection. Vox Sang. 67 (1994) 238-239
31. Hainaut M., Peltier C.A., Goetghebuer T., Van der Linden D., Marissens D., Zissis G., et al. Seroreversion in children infected with HIV type 1 who are treated in the first months of life is not a rare event. Clin. Infect. Dis. 41 (2005) 1820-1821